Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

LF13CMRI In vivo metabolic imaging at low magnetic field

Coordinator
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV, Germany
Runs
1 September 2024 to 31 October 2026
Status
Running
EU funding
€190k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101150649

What the project is doing

In the project's own words, from its summary on CORDIS.

Magnetic resonance imaging (MRI) is an excellent technique for medical diagnosis. Nonetheless, people from rural areas and low-income countries cannot access MRI due to its high associated cost. In recent years, low-field MRI has emerged as a potential solution to increase access to MRI, but at the cost of reduced signal sensitivity. This is a limiting factor in terms of resolution, traceable quantities of metabolites, and early detection of tumor tissue.

In this context, hyperpolarization (HP) has emerged as the most promising technique to compensate for the sensitivity losses at low magnetic fields. HP can enhance signal intensity by >10,000 times, providing enough signal to image even species at low concentrations, such as metabolites internalized by cancer cells. Here, the first in vivo metabolic imaging methodology with hyperpolarization at low magnetic fields is proposed.

The project involves the development of 1H and HP 13C MRI at low field, the study of enzymatic conversion from HP pyruvate to other metabolites, and in vivo metabolic tumor imaging in mice. Para-hydrogen-induced polarization (PHIP) will be used to generate the HP contrast agent. PHIP offers several advantages, including low costs, low instrumentation demands, rapid high-throughput, and scalable production of HP agents in the liquid state.

The combination of low-field MRI with PHIP 13C has the potential to provide a method for early cancer detection in a low-cost scanner.

Topics

Who is involved

OrganisationCityCountryRole
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI